Abstract
Summary A “hypopituitary” dwarf was treated during a 10-month period with human growth hormone (Raben12); there was a resultant spurt in growth associated with relatively slight, if any, maturation in body proportions and skeleton. Radiologic evidence of widening of the epiphyseal plates was noted. A constitutional or primordial dwarf was treated with similar amounts of growth hormone and failed to show significant reduction in urine nitrogen, changes in blood chemistries, or a spurt in linear growth. Neither patient had any apparent adverse reaction to the growth hormone.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
